Article Sidebar
Published:
Jun 6, 2017Article Details
Copyright remains in the Author’s name. The work is licensed under a Creative Commons Attribution - Noncommercial Works License. Authors are required to complete and sign an Author Agreement form that outlines Author and Publisher rights and terms of publication. The Agreement form should be uploaded along with other submissions files and any submission will be considered incomplete without it [forthcoming].
Material submitted for publication in the SAMJ is accepted provided it has not been published or submitted for publication elsewhere. Please inform the editorial team if the main findings of your paper have been presented at a conference and published in abstract form, to avoid copyright infringement. The SAMJ does not hold itself responsible for statements made by the authors.
Previously published images
If an image/figure has been previously published, permission to reproduce or alter it must be obtained by the authors from the original publisher and the figure legend must give full credit to the original source. This credit should be accompanied by a letter indicating that permission to reproduce the image has been granted to the author/s. This letter should be uploaded as a supplementary file during submission.
Main Article Content
Norplant in South Africa - the first 100 patients
Abstract
High maternal mortality rates coupled with poor socioeconomic conditions in developing countries indicate the need for those truly dedicated to improvement of maternal well-being to investigate advances in methods of pregnancy regulation and to. implement those found to be effective and acceptable.
In a trial involving 100 patients at Tygerberg Hospital that commenced in December 1993, Norplant was found to be highly acceptable and easy to use.
It is strongly recommended that the acceptability of Norplant to the general South African population be evaluated further and then, hopefully, made available to all our people without undue delay.
